308080 — ViGenCell Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩73bn
- KR₩31bn
Annual cashflow statement for ViGenCell, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -22,430 | -10,455 | -11,114 | -17,393 | -17,875 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 19,232 | 4,399 | 1,466 | 1,672 | -1,291 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 43.3 | -3,017 | -25.2 | 1,714 | -199 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2,958 | -8,192 | -7,955 | -11,089 | -15,267 |
| Capital Expenditures | -988 | -1,775 | -15,493 | -13,684 | -1,024 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -5,206 | -874 | -53,236 | 2,811 | 25,356 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -6,193 | -2,649 | -68,729 | -10,872 | 24,332 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 20,000 | -379 | 103,555 | -1,819 | 297 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 10,849 | -11,220 | 26,872 | -23,784 | 9,354 |